VIYASH
Viyash Scientific Limited (VIYASH) Stock Analysis
Viyash Scientific Limited provides contract research, testing, and scientific services to pharma and industrial clients. It supports product development and quality analysis from laboratories in India. The company is a listed scientific services business.
Healthcare › Drug Manufacturers - Specialty & Generic
₹226.00
-3.44% 1W | +15.10% 52W
Market Cap
10.0k CR
P/E Ratio
55.3
52W High
₹298
52W Low
₹178.1
Div. Yield
0%
Beta
1
50 DMA
₹253.8
200 DMA
₹233.4
Profit Margin
5.9%
Inst. Own.
10.8%
✅ BOUNCE FROM SUPPORT
✅ BOUNCE FROM SUPPORT
Fundamentals
Profit & Loss
| Metric | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 333 | 346 | 329 | 361 | 390 | 369 | 774 | 402 | 792 | 850 | 858 | 920 | 946 |
| Expenses | 341 | 331 | 307 | 329 | 348 | 330 | 674 | 355 | 673 | 677 | 683 | 736 | 768 |
| Operating Profit | -8 | 15 | 22 | 32 | 42 | 39 | 100 | 46 | 119 | 173 | 176 | 184 | 178 |
| OPM % | -2.5% | 4.4% | 7% | 9% | 11% | 11% | 13% | 12% | 15% | 20% | 20% | 20% | 19% |
| Other Income | -23 | 10 | 7 | -1 | 3 | 0 | 4 | 1 | 6 | 6 | -27 | 16 | 8 |
| Interest | 10 | 13 | 13 | 12 | 16 | 14 | 21 | 15 | 20 | 18 | 17 | 15 | 13 |
| Depreciation | 14 | 15 | 15 | 16 | 16 | 17 | 58 | 16 | 56 | 59 | 59 | 60 | 62 |
| Profit before tax | -56 | -3 | 1 | 3 | 12 | 8 | 24 | 16 | 48 | 102 | 73 | 125 | 112 |
| Tax % | -38% | 123% | -617% | 52% | 24% | 20% | -71% | 36% | 24% | 29% | 34% | 47% | 29% |
| Net Profit | -35 | -7 | 11 | 1 | 9 | 6 | 42 | 10 | 37 | 73 | 49 | 66 | 79 |
| EPS in Rs | -1.40 | -0.34 | 0.33 | -0.04 | 0.26 | 0.10 | 1.78 | 0.37 | 1.27 | 2.18 | 0.88 | 1.19 | 1.51 |
| Metric | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 443 | 606 | 684 | 848 | 1,039 | 1,179 | 1,362 | 1,413 | 1,421 | 1,370 | 3,007 | 3,420 | 3,575 |
| Expenses | 425 | 550 | 641 | 765 | 914 | 1,009 | 1,150 | 1,303 | 1,409 | 1,308 | 2,620 | 2,768 | 2,864 |
| Operating Profit | 18 | 56 | 43 | 83 | 125 | 170 | 212 | 109 | 12 | 61 | 387 | 653 | 711 |
| OPM % | 4.2% | 9% | 6% | 10% | 12% | 14% | 16% | 8% | 0.8% | 4.5% | 13% | 19% | 20% |
| Other Income | 48 | 14 | 9 | 436 | 9 | 10 | -0 | 11 | -58 | -6 | -49 | -1 | 3 |
| Interest | 43 | 38 | 28 | 33 | 33 | 36 | 24 | 16 | 36 | 48 | 86 | 69 | 61 |
| Depreciation | 32 | 46 | 40 | 41 | 42 | 51 | 51 | 52 | 56 | 62 | 239 | 234 | 240 |
| Profit before tax | -8 | -14 | -17 | 444 | 59 | 94 | 137 | 53 | -138 | -55 | 13 | 349 | 413 |
| Tax % | 40% | 19% | -3% | 3% | 3% | 13% | 24% | 15% | -11% | -46% | -20% | 36% | |
| Net Profit | -12 | -16 | -16 | 431 | 57 | 82 | 104 | 45 | -122 | -30 | 16 | 225 | 267 |
| EPS in Rs | -0.70 | -0.78 | -0.57 | 17.30 | 1.97 | 2.81 | 3.84 | 1.65 | -4.86 | -1.44 | 0.93 | 4.06 | 5.76 |
| Dividend Payout % | 0% | 0% | 0% | 1% | 10% | 0% | 13% | 0% | 0% | 0% | 0% | 0% |
Growth — CAGR
| Metric | 3Y | 5Y | 10Y |
|---|---|---|---|
| Revenue CAGR | 34.0% | 20.0% | 19.0% |
| Profit CAGR | 73.0% | 15.0% | 28.0% |
Shareholding Pattern
Promoters52.33%
FIIs5.90%
DIIs12.91%
Public28.69%
Promoters61.41%
FIIs3.16%
DIIs7.36%
Public27.97%
Promoters61.31%
FIIs2.94%
DIIs7.98%
Public27.67%
Promoters61.31%
FIIs4.50%
DIIs3.76%
Public30.34%
Promoters49.24%
FIIs2.60%
DIIs8.30%
Public39.76%
Promoters52.79%
FIIs5.89%
DIIs2.92%
Public38.00%
Promoters52.79%
FIIs6.16%
DIIs7.59%
Public33.29%
Promoters52.61%
FIIs6.05%
DIIs12.82%
Public28.36%
Promoters61.31%
FIIs2.94%
DIIs7.98%
Public27.67%
Promoters49.24%
FIIs2.60%
DIIs8.30%
Public39.76%
VIYASH
Holdings Analysis
Key strengths & risk signals
60
Overall
59
Fundamental
61
Technical
Risks (4)
LOW MARGIN! 5.9% profit margin - thin profits.
WEAK POSITION! Current price (226.0) is below both moving averages.
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.4% (1 week), 5.4% (1 month), 15.9% (3 months).
LOWER HALF! Trading at 39.9% of 52W range - weakness visible.
Strengths (4)
Cannot calculate PEG - insufficient growth data.
BULLISH TREND! 50-day average (253.8) is above 200-day average (233.4) - positive signal.
TESTING SUPPORT! Stock is at key support level.
APPROACHING OVERSOLD! RSI at 34.0 - watch for reversal.
Fundamental & Technical Analysis
60Overall
59Fundamental
61Technical
Fundamental Breakdown
Growth Quality
17/30
Revenue CAGR: 33.3% (EXCELLENT, 15/15). Profit CAGR: 0% (DECLINING, 2/15).
Profit Margin
3/10
LOW MARGIN! 5.9% profit margin - thin profits.
PEG Valuation
8/10
Cannot calculate PEG - insufficient growth data.
Dividend Yield
3/10
NEGLIGIBLE DIVIDEND! 0% yield - little to no income.
Debt to Equity
10/10
VERY LOW DEBT! D/E of 0.00 - excellent financial health.
Public Holding
10/20
SIGNIFICANT PUBLIC HOLDING! 37.64% public ownership - moderate retail influence.
Stability Index
8/10
GOOD STABILITY! Only 1 revenue dip in history. Strong business fundamentals.
Technical Breakdown
Moving Averages
12/10
BULLISH TREND! 50-day average (253.8) is above 200-day average (233.4) - positive signal.
Price Position
2/10
WEAK POSITION! Current price (226.0) is below both moving averages.
Trend Pattern
16/20
TESTING SUPPORT! Stock is at key support level.
52W Performance
6/10
POSITIVE YEAR! Stock gained 15.1% in the last year.
Volume Sentiment
15/30
BEARISH SENTIMENT! In last 30 days: 10 up days, 20 down days. Avg volume on up days: 2,215,317 vs down days: 2,471,192. Ratio: 0.9x
RSI
4/5
APPROACHING OVERSOLD! RSI at 34.0 - watch for reversal.
52W Range
2/5
LOWER HALF! Trading at 39.9% of 52W range - weakness visible.
Momentum
1/5
NEGATIVE MOMENTUM! Price declined across timeframes - down 3.4% (1 week), 5.4% (1 month), 15.9% (3 months).
Beta
3/5
MARKET ALIGNED! Beta of 1.00 - moves with the market.
VIYASH
Concall / Investor Presentation
Earnings call transcripts & AI summaries
| Quarter | Concall | Summary |
|---|---|---|
| Q1FY272026-08-16 | Concall PDF | |
| Q4FY262026-05-22 | Concall PDF | |
| Q3FY262026-02-09 | Concall PDF | |
| Q2FY262025-11-21 | Concall PDF |
Peer Comparison
Healthcare · Drug Manufacturers - Specialty & Generic · 8 stocks
| Stock | Price | P/E | Profit Margin | Revenue CAGR 5Y | Profit CAGR 5Y | 52W Change | Stock Strength | Trendline | YoY Profit | QoQ Profit | YoY Revenue | QoQ Revenue |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| VIYASH | ₹226.00 | 55.3 | 5.9% | 33.3% | – | +15.1% | 60 | BOUNCE FROM SUPPORT | +107.2% | +26.5% | +19.6% | +2.9% |
| STAR | ₹1,045.20 | 15.7 | 12.3% | 8.7% | – | +34.5% | 64 | BREAKDOWN | +57.5% | +23.6% | +13.0% | -4.4% |
| SEQUENT | ₹201.20 | 123.4 | 2.5% | 3.1% | -18.9% | +26.2% | 55 | CONSOLIDATION | -13.9% | +161.2% | +10.9% | +102.5% |
| AKUMS | ₹731.50 | 38.4 | 6.5% | 7.0% | 39.1% | +62.4% | 76 | BREAKDOWN | +57.5% | +18.2% | +13.9% | +0.8% |
| SUDEEPPHRM | ₹1,000.70 | 61.4 | 27.0% | 14.4% | 40.5% | +36.3% | 73 | BREAKDOWN | +31.8% | -17.0% | +26.7% | -13.2% |
| SUVEN | ₹303.60 | – | – | -19.3% | – | +49.1% | 55 | BREAKDOWN | +147.8% | +179.8% | +89.5% | +140.0% |
| PGHL | ₹5,200.00 | 24.2 | 24.9% | 8.2% | 19.3% | -16.2% | 71 | CONSOLIDATING DOWN | +45.3% | +1.7% | +7.4% | -1.8% |
| AARTIPHARM | ₹873.60 | 37.2 | 10.4% | -2.6% | -3.3% | +1.3% | 59 | CONSOLIDATING UP | +65.4% | +24.5% | +38.7% | -8.0% |
Data from TradeAlone · Updated daily
VIYASH News
Viyash Scientific Limited (NSE: Viyash) Announces Q1 FY27 Performance Highlights2026-08-12Viyash Scientific Limited (viyash) Q1 FY27: Revenues Up 19.5%, PAT Surges 114.9%2026-08-11Viyash Scientific Limited (VIYASH) gains 5% intraday, extends gains2026-06-22Viyash Scientific Limited (viyash) Further Strengthens European Companion Animal Presence2026-06-08Viyash Scientific Limited (viyash) Q4 FY26: Record Ebitda, PAT Surges 306%2026-05-19
